FDA Inspection 1225704 — Richard A. Shlofmitz, MD

Richard A. Shlofmitz, MD — FEI 3006616470

The FDA completed an inspection of Richard A. Shlofmitz, MD on December 7, 2023 in Roslyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 7, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Roslyn, NY (United States)

Additional Details

Clinical Investigator (CI)